Composition for forming organic film, patterning process, and compound
US-12584023-B2 · Mar 24, 2026 · US
US10479749B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-10479749-B2 |
| Application number | US-201816014401-A |
| Country | US |
| Kind code | B2 |
| Filing date | Jun 21, 2018 |
| Priority date | Jun 21, 2017 |
| Publication date | Nov 19, 2019 |
| Grant date | Nov 19, 2019 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
Disclosed is a novel process for the isolation of bioactive compounds from Terminalia arjuna. More specifically, the invention discloses a process for isolation and enrichment of bioactive compounds Arjunic acid, Arjunolic acid, Arjungenin, Arjunetin, Arjunoglucoside-I, Arjunoglucoside-II, and Catechin from the bark of Terminalia arjuna. The invention also discloses a composition standardized to contain 3% arjunoglucosides isolated from the bark of Terminalia arjuna.
Opening claim text (preview).
We claim: 1. A process for the isolation of standardized composition comprising of arjunoglucoside from bark of Terminalia arjuna , said process comprising steps of: (a) Charging Terminalia arjuna bark powder into an extractor, (b) Adding 3 volumes of ethanol or methanol to Terminalia arjuna bark powder and refluxing for 3 hours at 65 to 70° C., (c) Filtering the ethanol or methanol extract of step b) and concentrating under vacuum to get a brown coloured powder, (d) Dissolving the powder obtained from step c) into 5 volumes of de-mineralize water and stirring thoroughly for 1 hr at 50-55° C. to obtain a solution, (e) Transferring the solution from step d) to separating funnel and extracting with 2 volumes of ethyl acetate, 6 times, and separating the aqueous and organic layer, (f) Collecting and combining the ethyl acetate fractions 1-6 from step e and concentrating under vacuum to obtain brown coloured powder, (g) Loading the powder of step 1) into a silica gel and eluting with chloroform:methanol, (h) Identifying the compounds from step g) as Arjunic acid corresponding to STR#1, Arjunolic acid corresponding to STR#2, Arjungenin corresponding to STR#3, Arjunoglucoside-I corresponding to STR#4, Arjunoglucoside-II corresponding to STR#5, Arjunetin corresponding to STR#6, and catechin corresponding to STR#7 2. A process for enriching arjunoglucoside II, said process comprising steps of: (a) Charging Terminalia arjuna bark powder into an extractor, (b) Adding 3 volumes of ethanol or methanol to Terminalia arjuna bark powder and refluxing for 3 hours at 65 to 70° C., (c) Filtering the ethanol or methanol extract of step b) and concentrating under vacuum to get a brown coloured powder, Assay of arjunoglucoside-II by HPLC=0.55% w/w (d) Dissolving the powder obtained from step c) into 5 volumes of de-mineralize water and stirring thoroughly for 1 hr at 50-55° C. to obtain a solution, (e) Transferring the solution from step d) to separating funnel and extracting with 2 volumes of ethyl acetate, 6 times, and separating the aqueous and organic layer, (f) Collecting and combining the ethyl acetate fractions 1-6 from step e and concentrating under vacuum to obtain brown coloured powder, Assay of arjunoglucoside-II by HPLC=20-21% w/w. 3. A composition comprising at-least 3% arjunoglucosides wherein said composition comprises Arjunic acid corresponding to STR#1, Arjunolic acid corresponding to STR#2, Arjungenin corresponding to STR#3, Arjunoglucoside-I corresponding to STR#4, Arjunoglucoside-I corresponding to STR#5, Arjunetin corresponding to STR#6, and catechin corresponding to STR#7
Antivirals · CPC title
Antineoplastic agents · CPC title
polycyclic · CPC title
Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine · CPC title
Myrtaceae (Myrtle family), e.g. teatree or eucalyptus · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.